MindMaze Raises $105M in Funding

MindMaze, a digital neurotherapeutics solutions provider, has raised $105 million in funding led by Concord Health Partners, AlbaCore Capital Group and Hambro Perks. The company plans to use the funds to accelerate its global commercial growth plans, charge ongoing R&D and consolidate the clinical development pipeline of its digital therapeutic solutions for a wide spectrum of neurological diseases.

MindMaze Secures $105M to Advance Digital Neurotherapeutics

MindMaze is a Lausanne, Switzerland, London, UK- and Baltimore, MD-based digital neurotherapeutics solutions provider that focuses on advancing digital neuro-therapeutics (DTx) solutions with to accelerate the brain’s ability to recover, learn and adapt. With over a decade of work at the intersection of neuroscience, bio-sensing, engineering, mixed reality and artificial intelligence, its healthcare division is addressing some of the most challenging problems in neurology, including stroke, Alzheimer disease and Parkinson disease, by creating a platform for brain health and recovery and unique digital therapeutic interventions.

MindMaze is a digital neurotherapeutics solutions provider that focuses on advancing digital neuro-therapeutics (DTx) solutions with to accelerate the brain’s ability to recover, learn and adapt.

3 years ago

MindMaze Secures $105M to Advance Digital Neurotherapeutics

ProblemHealthcare

Solution

Covered on